Cardiac dysautonomia in huntington’s disease

Journal of Huntington's Disease

Volumn 2, Issue 3, 2013, Pages 251-261

  Abildtrup, Mads ^a   Shattock, Michael ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Rayne Institute   (United Kingdom)

Author keywords

Arrhythmias; BDNF; Cardiac death; Dysautonomia; Heart disease; Heart rate variability; Huntington s disease

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ANIMAL; ARRHYTHMIAS; AUTONOMIC NERVOUS SYSTEM; DYSAUTONOMIA; HEART DEATH; HEART DISEASE; HEART RATE VARIABILITY; HUMAN; HUNTINGTON CHOREA; PATHOPHYSIOLOGY; REVIEW;

ARRHYTHMIAS; BDNF; CARDIAC DEATH; DYSAUTONOMIA; HEART DISEASE; HEART RATE VARIABILITY; HUNTINGTON'S DISEASE;

ANIMALS; AUTONOMIC NERVOUS SYSTEM; HEART DISEASES; HUMANS; HUNTINGTON DISEASE; PRIMARY DYSAUTONOMIAS;

EID: 84907193989     PISSN: 18796397     EISSN: 18796400     Source Type: Journal    
DOI: 10.3233/JHD-130054     Document Type: Article

References (131)

1. Bates GP. History of genetic disease: The molecular genetics of Huntington disease - a history. Nat Rev Genet. 2005;6: 766-73.
2. Walker FO. Huntington’s disease. Lancet 2007;369: 218-28.
3. Saudou F, Finkbeiner S, Devys D, Greenberg ME. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 1998;95: 55-66.
4. Munoz-Sanjuan I, Bates GP. The importance of integrating basic and clinical research toward the development of new therapies for Huntington disease. J Clin Invest. 2011;121: 476-83.
5. Bano D, Zanetti F, Mende Y, Nicotera P. Neurodegenerative processes in Huntington’s disease. Cell Death Dis. 2011;2: e228.
6. Andrew SE, Goldberg YP, Kremer B, Telenius H, Theilmann J, Adam S, Starr E, Squitieri F, Lin B, Kalchman MA, Graham RK, Hayden MR. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington’s disease. Nat Genet. 1993;4: 398-403.
7. Snell RG, MacMillan JC, Cheadle JP, Fenton I, Lazarou LP, Davies P, MacDonald ME, Gusella JF, Harper PS, Shaw DJ. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington’s disease. Nat Genet. 1993;4: 393-97.
8. Ross CA, Tabrizi SJ. Huntington’s disease: From molecular pathogenesis to clinical treatment. Lancet Neurol. 2011; 10: 83-98.
9. Sassone J, Colciago C, Cislaghi G, Silani V, Ciammola A. Huntington’s disease: The current state of research with peripheral tissues. Exp Neurol. 2009;219: 385-97.
10. Van der Burg JM, Bjorkqvist M, Brundin P. Beyond the brain: Widespread pathology in Huntington’s disease. Lancet Neurol. 2009;8: 765-74.
11. Chiu E, Alexander L. Causes of death in Huntington’s disease. Med J Aust. 1982;1: 153.
12. Conneally PM. Huntington disease: Genetics and epidemiology. Am J Hum Genet. 1984;36: 506-26.
13. Haines JL, Conneally PM. Causes of death in Huntington disease as reported on death certificates. Genet Epidemiol. 1986;3: 417-23.
14. Lanska DJ, Lavine L, Lanska MJ, Schoenberg BS. Huntington’s disease mortality in the United States. Neurology 1988;38: 769-72.
15. Sorensen SA, Fenger K. Causes of death in patients with Huntington’s disease and in unaffected first degree relatives. J Med Genet. 1992;29: 911-14.
16. Heemskerk AW, Roos RAC. Aspiration pneumonia and death in Huntington’s disease. PLoS Curr 2012: doi: 10.1371/currents.RRN1293.
17. Schonberger SJ, Jezdic D, Faull RLM, Cooper GJS. Proteomic Analysis of the Human Brain in Huntington’s Disease Indicates Pathogenesis by Molecular Processes Linked to other Neurodegenerative Diseases and to Type-2 Diabetes. Journal of Huntington’s Disease 2013;2: 89-99.
18. Lanska DJ, Lanska MJ, Lavine L, Schoenberg BS. Conditions associated with Huntington’s Disease and death. A case control study. Arch Neurol. 1988;45: 878-80.
19. CDC/NCHS, AHA. National Health and Nutrition Examination Study (NHANES III). 1988-94. CDC/ NCHS and the American Heart Association.
20. Mihm MJ, Amann DM, Schanbacher BL, Altschuld RA, Bauer JA, Hoyt KR. Cardiac dysfunction in the R6/2 mouse model of Huntington’s disease. Neurobiol Dis. 2007;25: 297-308.
21. Pattison JS, Sanbe A, Maloyan A, Osinska H, Klevitsky R, Robbins J. Cardiomyocyte Expression of a Polyglutamine Preamyloid Oligomer Causes Heart Failure. Circulation 2008;117: 2743-51.
22. Wood NI, Sawiak SJ, Buonincontri G, Niu Y, Kane AD, Carpenter TA, Giussani DA, Morton AJ. Direct Evidence of Progressive Cardiac Dysfunction in a Transgenic Mouse Model of Huntington’s Disease. Journal of Huntington’s Disease 2012;1: 57-64.
23. Kiriazis H, Jennings NL, Davern P, Lambert G, Su Y, Pang T, Du X, La Greca L, Head GA, Hannan AJ, Du XJ. Neurocardiac dysregulation and neurogenic arrhythmias in a transgenic mouse model of Huntington’s disease. J Physiol. 2012;15: 1-16.
24. Aziz NA, Anguelova GV, Marinus J, van Dijk JG, Roos RA. Autonomic symptoms in patients and pre-manifest mutation carriers of Huntington’s disease. Eur J Neurol. 2010;17: 1068-74.
25. Aziz NA, Ross RA. Autonomic Symptoms in Huntington’s Disease - Current Understanding and Perspectives for the Future. Eur Neurol Review. 2010;5: 46-48.
26. Andrich J, Schmitz T, Saft C, Postert T, Kraus P, Epplen JT, Przuntek H, AgelinkMW. Autonomic nervous system function in Huntington’s disease. J Neurol Neurosurg Psychiatry. 2002;72: 726-31.
27. Bar KJ, Boettger MK, Andrich J, Epplen JT, Fischer F, Cordes J, Koschke M, Agelink MW. Cardiovagal modula tion upon postural change is altered in Huntington’s disease. Eur J Neurol. 2008;15: 869-71.
28. Den Heijer JC, Bollen WL, Reulen JP, van Dijk JG, Kramer CG, Roos RA, Buruma OJ. Autonomic nervous function in Huntington’s disease. Arch Neurol. 1988;45: 309-12.
29. Sharma KR, Romano JG, Ayyar DR, Rotta FT, Facca A, Sanchez-Ramos J. Sympathetic skin response and heart rate variability in patients with Huntington disease. Arch Neurol. 1999;56: 1248-52.
30. Kobal J, Meglic B, Mesec A, Peterlin B. Early sympathetic hyperactivity in Huntington’s disease. Eur J Neurol. 2004; 11: 842-48.
31. Eckberg DL. Sympathovagal balance: A critical appraisal. Circulation 1997;96: 3224-32.
32. Goldstein DS, Bentho O, Park MY, Sharabi Y. Lowfrequency power of heart rate variability is not a measure of cardiac sympathetic tone but may be a measure of modulation of cardiac autonomic outflows by baroreflexes. Exp Physiol. 2011;96: 1255-61.
33. Weimer LM. Autonomic testing: Common techniques and clinical applications. Neurologist 2010;16: 215-22.
34. Heathers JAJ. Sympathovagal balance from heart rate variability: An obituary. Exp Physiol. 2012;97: 556.
35. Nicolini P, Ciulla MM, Asmundis CD, Magrini F, Brugada P. The prognostic value of heart rate variability in the elderly, changing the perspective: From sympathovagal balance to chaos theory. Pacing Clin Electrophysiol. 2012;35: 622-38.
36. Pagani M, Lucini D, Porta A. Sympathovagal balance from heart rate variability: Time for a second round? Exp Physiol. 2012;97: 1141-42.
37. Kobal J, Melik Z, Cankar K, Bajrovic FF, Meglic B, Peterlin B, Zaletel M. Autonomic dysfunction in presymptomatic and early symptomatic Huntington’s disease. Acta Neurol Scand. 2010;121: 392-99.
38. Schwartz PJ, Zipes DP. Autonomic regulation of cardiac arrhythmias. In Cardiac Electrophysiology From bench to Bedside, ed. Zipes DP, Jalife J, Saunders WB, Philadelphia, 2004.
39. Ng GA, Brack KE, Patel VH, Coote JH. Autonomic modulation of electrical restitution, alternans and ventricular fibrillation in the isolated heart. Cardiavasc Res. 2007;73: 750-60.
40. Molgaard H, Sorensen KE, Bjerregaard P. Attenuated 24-h heart rate variability in apparently healthy subjects, subsequently suffering sudden cardiac death. Clin Auton Res. 1991;1: 233-37.
41. Algra A, Tijssen JGP, Roelandt JRTC, Pool J, Lubsen J. Heart rate variability from 24-hour electrocardiography and the 2-year risk for sudden death. Circulation 1993;88: 180-85.
42. Schwartz PJ. The autonomic nervous system and sudden death. Eur Heart J. 1998;19: 72-80.
43. Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med. 2001;345: 1473-82.
44. Bayés de Luna A, Elosua R. Sudden Death. Rev Esp Cardiol. 2012;65: 1039-52.
45. Crook ZR, Housman D. Huntington’s Disease: Can Mice Lead the Way to Treatment? Neuron 2011;69: 423-35.
46. Kudo T, Schroeder A, Loh DH, Kuljis D, Jordan MC, Roos KP, Colwell CS. Dysfunctions in circadian behavior and physiology in mouse models of Huntington’s disease. Exp Neurol. 2011;228: 80-90.
47. Schroeder AM, Loh DH, Jordan MC, Roos KP, Colwell CS. Baroreceptor reflex dysfunction in the BACHD mouse model of Huntington’s disease. PLoS Curr. 2011;3: RRN1266.
48. Griffioen KJ, Wan R, Brown TR, Okun E, Camandola S, Mughal MR, Phillips TM, Mattson MP. Aberrant heart rate and brainstem brain-derived neurotrophic factor (BDNF) signaling in a mouse model of Huntington’s disease. Neurobiol Aging. 2012;33: 1481 e1-1481.e5.
49. Gray M, Shirasaki DI, Cepeda C, Andre VM, Wilburn B, Lu XH, Tao J, Yamazaki I, Li SH, Sun YE, Li XJ, Levine MS, Yang XW. Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice. J Neurosci. 2008;28: 6182-95.
50. Benarroch EE. The arterial baroreflex: Functional organization and involvement in neurologic disease. Neurology 2008;71: 1733-38.
51. La Rovere MT, Pinna GD, Raczak G. Baroreflex sensitivity: Measurement and clinical implications. Ann Noninvasive Electrocardiol. 2008;13: 191-207.
52. Aminoff MJ, Gross M. Vasoregulatory activity in patients with Huntington’s chorea. J Neurol Sci. 1974;21: 33-38.
53. Morton AJ, Wood NI, Hastings MH, Hurelbrink C, Barker RA, Maywood ES. Disintegration of the sleep-wake cycle and circadian timing in Huntington’s disease. J Neurosci. 2005;25: 157-63.
54. Kaye DM, Lambert GW, Lefkovits J, Morris M, Jennings G, Esler MD. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. J Am Coll Cardiol. 1994;23: 570-78.
55. Himura Y, Felten SY, Kashiki M, Lewandowski TJ, Delehanty JM, Liang CS. Cardiac noradrenergic nerve terminal abnormalities in dogs with experimental congestive heart failure. Circulation 1993;88: 1299-1309.
56. Stober T, Sen S, Burger L. Bradycardia and second-degree AV block: An expression of the dominance of cholinergic activity in the rigid form of Huntington’s disease. J Neurol. 1983;229: 129-32.
57. Sörös P, Hachinski V. Cardiovascular and neurological causes of sudden death after ischaemic stroke. Lancet Neurol. 2012;11: 179-88.
58. Shattock MJ, Tipton MJ. ‘Autonomic Conflict’: A different way to die during cold water immersion? J Physiol. 2012; 590: 3219-30.
59. Tipton MJ, Kelleher P, Golden FS. Supraventricular arrhythmias following breath-hold submersions in cold water. Undersea Hyperb Med. 1994;21: 305-13.
60. Tipton M, Gibbs P, Brooks C, Roiz de Sa D, Reilly T. ECG during the first helicopter underwater escape training (HUET) submersions of novice trainees. Physiological Society Meeting, King’s College London. London, UK: Proceedings of the Physiological Society 2009;14: PC24.
61. Sharifov OF, Fedorov VV, Beloshapko GG, Glukhov AV, Yushmanova AV, Rosenshtraukh LV. Roles of adrenergic and cholinergic stimulation in spontaneous atrial fibrillation in dogs. J Am Coll Cardiol. 2004;43: 483-90.
62. Tan AY, Zhou S, Ogawa M, Song J, Chu M, Li H, Fishbein MC, Lin SF, Chen LS, Chen PS. Neural mechanisms of paroxysmal atrial fibrillation and paroxysmal atrial tachycardia in ambulatory canines. Circulation 2008;118: 916-25.
63. Shen MJ, Choi EK, Tan AY, Lin SF, Fishbein MC, Chen LS, Chen PS. Neural mechanisms of atrial arrhythmias. Nat Rev Cardiol. 2011;9: 30-39.
64. Cechetto DF, Shoemaker JK. Functional neuroanatomy of autonomic regulation. Neuroimage 2009;47: 795-803.
65. Thayer JF, Lane RD. Claude Bernard and the heart-brain connection: Further elaboration of a model of neurovisceral integration. Neurosci Biobehav Rev. 2009;33: 81-88.
66. Kimmerly DS, O’Leary DD, Menon RS, Gati JS, Shoemaker JK. Cortical regions associated with autonomic cardiovascular regulation during lower body negative pressure in humans. J Physiol. 2005;569: 331-45.
67. Pasquini M, Laurent C, Kroumova M, Masse I, Deplanque D, Leclerc X, Bordet R, Leys D. Insular infarcts and electrocardiographic changes at admission: Results of the PRognostic of Insular CErebral infarctS Study (PRINCESS). J Neurol. 2006;253: 618-24.
68. Nagai M, Hoshide S, Kario K. The insular cortex and cardiovascular system: A new insight into the brain-heart axis. J Am Soc Hypertens. 2010;4: 174-82.
69. Melik Z, Kobal J, Cankar K, Strucl M. Microcirculation response to local cooling in patients with Huntington’s disease. J Neurol. 2012;259: 921-28.
70. Freeman R. Assessment of cardiovascular autonomic function. Clin Neurophysiol. 2006;117: 716-30.
71. Rosas HD, Hevelone ND, Zaleta AK, Greve DN, Salat DH, Fischl B. Regional cortical thinning in preclinical Huntington disease and its relationship to cognition. Neurology 2005;65: 745-47.
72. Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RA, Durr A, Craufurd D, Kennard C, Hicks SL, Fox NC, Scahill RI, Borowsky B, Tobin AJ, Rosas HD, Johnson H, Reilmann R, Landwehrmeyer B, Stout JC; TRACK-HD investigators. Biological and clinical manifestations of Huntington’s disease in the longitudinal TRACK-HD study: Cross-sectional analysis of baseline data. Lancet Neurol. 2009;8: 791-801.
73. Tabrizi SJ, Scahill RI, Durr A, Roos RA, Leavitt BR, Jones R, Landwehrmeyer GB, Fox NC, Johnson H, Hicks SL, Kennard C, Craufurd D, Frost C, Langbehn DR, Reilmann R, Stout JC; TRACK-HD Investigators. Biological and clinical changes in premanifest and early stage Huntington’s disease in the TRACK- HD study: The 12-month longitudinal analysis. Lancet Neurol. 2011;10: 31-42.
74. Van den Bogaard SJ, Dumas EM, Acharya TP, Johnson H, Langbehn DR, Scahill RI, Tabrizi SJ, van Buchem MA, van der Grond J, Roos RA; TRACK-HD Investigator Group. Early atrophy of pallidum and accumbens nucleus in Huntington’s disease. J Neurol. 2011;258: 412-20.
75. Petersen A, Gabery S. Hypothalamic and limbic system changes in Huntington’s disease. Journal of Huntington’s disease 2012;1: 13-24.
76. Tabrizi SJ, Reilmann R, Roos RA, Durr A, Leavitt B, Owen G, Jones R, Johnson H, Craufurd D, Hicks SL, Kennard C, Landwehrmeyer B, Stout JC, Borowsky B, Scahill RI, Frost C, Langbehn DR;TRACK-HD investigators. Potential endpoints for clinical trials in premanifest and early Huntington’s disease in the TRACK-HD study: Analysis of 24 month observational data. Lancet Neurol. 2012;11: 42-53.
77. Dogan I, Eickhoff, SB, Schulz JB, Shah NJ, Laird AR, Fox PT, Reetz K. Consistent neurodegeneration and its association with clinical progression in Huntington’s disease: A coordinate-based meta-analysis. Neurodegener Dis. 2012;DOI: 10.1159/000339528.
78. Beste C, Saft C, Yordanova J, Andrich J, Gold R, Falkenstein M, Kolev V. Functional compensation or pathology in cortico-subcortical interactions in preclinical Huntington’s disease? Neuropsychologia. 2007;45: 2922-30.
79. Paulsen JS (2009) Functional imaging in Huntington’s disease. Exp Neurol. 2009;216: 272-77.
80. Nguyen L, Bradshaw JL, Stout JC, Croft RJ, Georgiou-Karistianis N. Electrophysiological measures as potential biomarkers in Huntington’s disease: Review and future directions. Brain Res Rev. 2010;64: 177-94.
81. Oppenheimer SM, Wilson JX, Guiraudon C, Cechetto DF. Insular cortex stimulation produces lethal cardiac arrhythmias: A mechanism of sudden death? Brain Res. 1991;550: 115-21.
82. Tokgözoglu SL, Batur MK, Top uoglu MA, Saribas O, Kes S, Oto A. Effects of stroke localization on cardiac autonomic balance and sudden death. Stroke 1999;30: 1301-11.
83. Abboud H, Berroir S, Labreuche J, Orjuela K, Amarenco P. Insular involvement in brain infarction increases risk for cardiac arrhythmia and death. Ann Neurol. 2006;59: 691-99.
84. Oppenheimer SM, Cechetto DF. Cardiac chronotropic organization of the rat insular cortex. Brain Res. 1990;533: 66-72.
85. Zamrini EY, Meador KJ, Loring DW, Nichols FT, Lee GP, Figueroa RE, Thompson WO. Unilateral cerebral inactivation produces differential left/right heart rate responses. Neurology 1990;40: 1408-11.
86. Oppenheimer SM, Kedem G, Martin WM. Left-insular cortex lesions perturb cardiac autonomic tone in humans. Clin Auton Res. 1996;6: 131-40.
87. Oppenheimer SM. Cerebrogenic cardiac arrhythmias: Cortical lateralization and clinical significance. Clin Auton Res. 2006;16: 6-11.
88. Macey PM, Wu P, Kumar R, Ogren JA, Richardson HL, Woo MA, Harper RM. Differential responses of the insular cortex gyri to autonomic challenges. Auton Neurosci. 2012;168: 72-81.
89. Thieben MJ, Duggins AJ, Good CD, Gomes L, Mahant N, Richards F, McCusker E, Frackowiak RS. The distribution of structural neuropathology in pre-clinical Huntington’s disease. Brain 2002;125: 1815-28.
90. Kassubek J, Juengling FD, Kioschies T, Henkel K, Karitzky J, Kramer B, Ecker D, Andrich J, Saft C, Kraus P, Aschoff AJ, Ludolph AC, Landwehrmeyer GB. Topography of cerebral atrophy in early Huntington’s disease: A voxel based morphometric MRI study. J Neurol Neurosurg Psychiatry. 2004;75: 213-20.
91. Douaud G, Gaura V, Ribeiro MJ, Lethimonnier F, Maroy R, Verny C, Krystkowiak P, Damier P, Bachoud-Levi AC, Hantraye P, Remy P. Distribution of grey matter atrophy in Huntington’s disease patients: A combined ROI-based and voxel-based morphometric study. Neuroimage 2006;32: 1562-75.
92. Yang AC, Chen TJ, Tsai SJ, Hong CJ, Kuo CH, Yang CH, Kao KP. BDNF Val66Met polymorphism alters sympathovagal balance in healthy subjects. Am J Med Genet B Neuropsychiatr Genet. 2010;153: 1024-30.
93. Altar CA, Cai N, Bliven T, Juhasz M, Conner JM, Acheson AL, Lindsay RM, Wiegand SJ. Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 1997;389: 856-60.
94. Hofer M, Paglisui SR, Hohn A, Leibrock J, Barde YA. Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J. 1990;9: 2459-64.
95. Yan Q, Radeke MJ, Matheson CR, Talvenheimo J, Welcher AA, Feinstein SC. Immunocytochemical localization of TrkB in the central nervous system of the adult rat. J Comp Neurol. 1997;378: 135-57.
96. Schober A, Wolf N, Huber K, Hertel R, Krieglstein K, Minichiello L, Kahane N, Widenfalk J, Kalcheim C, Olson L, Klein R, Lewin GR, Unsicker K. TrkB and neurotrophin 4 are important for development and maintenance of sym pathetic preganglionic neurons innervating the adrenal medulla. J Neurosci. 1998;18: 7272-84.
97. Clark CG, Hasser EM, Kunze DL, Katz DM, Kline DD. Endogenous brain-derived neurotrophic factor in the nucleus tractus solitarius tonically regulates synaptic and autonomic function J Neurosci. 2011;31: 12318-29.
98. Okada S, Yokoyama M, Toko H, Tateno K, Moriya J, Shimizu I, Nojima A, Ito T, Yoshida Y, Kobayashi Y, Katagiri H, Minamino T, Komuro I. Brain-derived neurotrophic factor protects against cardiac dysfunction after myocardial infarction via a central nervous system-mediated pathway. Arterioscler Thromb Vasc Bio. 2012;32: 1902-09.
99. Zuccato C, Ciammola A, Rigamonti D, Leavitt BR, Goffredo D, Conti L, MacDonald ME, Friedlander RM, Silani V, Hayden MR, Timmusk T, Sipione S, Cattaneo E. Loss of huntingtin-mediated BDNF gene transcription in Huntington’s disease. Science 2001;293: 493-98.
100. Zuccato C, Marullo M, Conforti P, MacDonald ME, Tartari M, Cattaneo E. Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington’s disease. Brain Pathol. 2008;18: 225-38.
101. Gambazzi L, Gokce O, Seredenina T, Katsyuba E, Runne H, Markram H, Giugliano M, Luthi-Carter R. Diminished activity-dependent brain-derived neurotrophic factor expression underlies cortical neuron microcircuit hypoconnectivity resulting from exposure to mutant huntingtin fragments. J Pharmacol Exp Ther. 2010;335: 13-22.
102. Gharami K, Xie Y, An JJ, Tonegawa S, Xu B. Brainderived neurotrophic factor over-expression in the forebrain ameliorates Huntington’s disease phenotypes in mice. J Neurochem. 2008;105: 369-79.
103. Paulsen JS, Ready RE, Hamilton JM, MegaM, Cummings J. Neuropsychiatric aspects of Huntington’s disease. J Neurol Neurosurg Psychiat. 2001;71: 310-14.
104. Van Duijn E, Kingma EM, van der Mast RC. Psychopathology in verified Huntington’s disease gene carriers. J Neuropsychiatry Clin Neurosci. 2007;19: 441-48.
105. Taggart P, Boyett MR, Logantha S, Lambiase PD. Anger, emotion and arrhythmias: From brain to heart. Front Physiol. 2011; 2: 67-74.
106. Nemeroff CB, Goldschmidt-Clermont PJ. Heartache and heartbreak-the link between depression and cardiovascular disease. Nat Rev Cardio. 2012;9: 526-39.
107. Leung YW, Flora DB, Gravely S, Irvine J, Carney RM, Grace SL. The impact of premorbid and postmorbid depression onset on mortality and cardiac morbidity among patients with coronary heart disease: Meta-analysis. Psychosom Med. 2012;74: 786-801.
108. Kemp AH, Quintana DS, Felmingham KL, Matthews S, Jelinek HF. Depression, Comorbid Anxiety Disorders, and Heart Rate Variability in Physically Healthy, Unmedicated Patients: Implications for Cardiovascular Risk. PLoS ONE 2012;7: e30777 doi: 10.1371/journal.pone.0030777.t002.
109. Goldstein DS. Dysautonomia in Parkinson’s disease: Neurocardiological abnormalities. Lancet Neurol. 2003;2: 669-76.
110. Chaudhuri KR. Autonomic dysfunction in movement disorders. Curr Opin Neurol. 2001;14: 505-511.
111. Asahina M, Vichayanrat E, Low DA, Iodice V, Mathias CJ. Autonomic dysfunction in parkinsonian disorders: Assessment and pathophysiology. J Neurol Neurosurg Psychiat. 2012;doi: 10.1136/jnnp-2012-303135.
112. Jecmenica-Lukic M, Poewe W, Tolosa E, Wenning GK. Premotor signs and symptoms of multiple system atrophy. Lancet Neurol. 2012;11: 361-68.
113. Idiaquez J, Roman GC. Autonomic dysfunction in neurodegenerative dementias. J Neurol Sci. 2011;305: 22-27.
114. Goldstein DS. Cardiac ectopy in chronic autonomic failure. Clin Auton Res. 2010;20: 85-92.
115. Oka H, Toyoda C, Yogo M, Mochio S. Cardiovascular dysautonomia in de novo Parkinson’s disease without orthostatic hypotension. Eur J Neurol. 2010;18: 286-92.
116. Bennett DA, Beckett LA, Murray AM, Shannon KM, Goetz CG, Pilgrim DM, Evans DA. Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med. 1996;33: 471-76.
117. Ben-Shlomo Y, Marmot MG. Survival and cause of death in cohort patients with parkinsonism: Possible clues to aetiology? J Neurol Neurosurg Psychiat. 1995;58: 293-99.
118. Szili-Török T, Kálmán J, Paprika D, Dibó G, Rózsa Z, Rudas L. Depressed baroreflex sensitivity in patients with Alzheimer’s and Parkinson’s disease. Neurobiol Aging. 2001;22: 435-438.
119. Furushima H, Niwano S, Chinushi M, Yamaura M, Taneda K, Washizuka T, Aizawa Y. Effect of atropine on QT prolongation and torsade de pointes induced by intracoronary acetylcholine in the long QT syndrome. Am J Cardiol. 1999;83: 714-18.
120. Castellanos A, Moleiro F, Lopera G, Huikuri H, Interian A Jr, Myerburg RJ. Dynamics of the uncorrected QT interval during vagal-induced lengthening of RR intervals. Am J Cardiol. 2000;86: 1390-92.
121. Farkas A, Dempster J, Coker SJ. Importance of vagally mediated bradycardia for the induction of torsade de pointes in an in vivo model. Br J Pharmacol. 2008;154: 958-70.
122. Grace AA, Roden DM. Systems biology and cardiac arrhythmias. Lancet 2012;380: 1498-1508.
123. Roden DM. Long-QT syndrome. N Engl J Med. 2008;358: 169-76.
124. Fossa AA, Wisialowski T, Crimin K. QT prolongation modifies dynamic restitution and hysteresis of the beat-to-beat QT-TQ interval relationship during normal sinus rhythm under varying states of repolarization. J Pharmacol Exp Ther. 2006;316: 498-506.
125. Yap YG, Camm AJ. Drug induced QT prolongation and torsades de pointes. Heart 2003;89: 1363-72.
126. Brodde OE, Bruck H, Leineweber K, Seyfarth T. Presence, distribution and physiological function of adrenergic and muscarinic receptor subtypes in the human heart. Bas Res Cardiol. 2001;96: 528-38.
127. Kawano H, Okada R, Yano K. Histological study on the distribution of autonomic nerves in the human heart. Heart Vessels 2003;18: 32-39.
128. Osuala K, Telusma K, Khan SM, Wu S, Shah M, Baker C, Alam S, Abukenda I, Fuentes A, Seifein HB, Ebert SN. Distinctive Left-Sided Distribution of Adrenergic-Derived Cells in the Adult Mouse Heart. PLoS ONE 2001;6: e22811.
129. Houmsse M, Tyler J, Kalbfleisch S. Supraventricular tachycardia causing heart failure. Curr Opin Cardiol. 2011;26: 261-69.
130. Abboud FM. The Walter B. Cannon Memorial Award Lecture, 2009. Physiology in perspective: The wisdom of the body. In search of autonomic balance: The good, the bad, and the ugly. Am J Physiol Regul Integr Comp Physiol. 2010;298: R1449-67.
131. Curtis MJ, Hancox JC, Farkas A, Wainwright CL, Stables CL, Saint DA, Clements-Jewery H, Lambiase PD, Billman GE, Janse MJ, PugsleyMK, Ng GA, Roden DM, Camm AJ, Walker MJ. The Lambeth Conventions (II): Guidelines for the study of animal and human ventricular and supraventricular arrhythmias. Pharmacol Ther. 2013;139: 213-48.